Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics

Ophthalmology

Volumn 120, Issue 10, 2013, Pages 2130-2138

  Von Holstein, Sarah L ^a,b   Fehr, André ^b   Persson, Marta ^b   Therkildsen, Marianne H ^c   Prause, Jan U ^a   Heegaard, Steffen ^a,d   Stenman, Göran ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PROTEIN BCL 2; PROTEIN MYB;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE DOSAGE; GENE EXPRESSION; GENE FUSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE TARGETING; HUMAN; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND TUMOR; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE MYB; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND;

ADULT; AGED; CARCINOMA, ADENOID CYSTIC; EYE NEOPLASMS; FEMALE; GENES, MYB; HUMANS; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-MYB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84885021417     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.03.030     Document Type: Article

References (50)

1. B. Esmaeli, M.A. Ahmadi, and A. Youssef Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland Ophthal Plast Reconstr Surg 20 2004 22 26
2. S.M. Ahmad, B. Esmaeli, and M. Williams American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma Ophthalmology 116 2009 1210 1215
3. N. Li, L. Xu, and H. Zhao A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry Cancer 118 2012 3945 3953
4. S.L. von Holstein, M.H. Therkildsen, and J.U. Prause Lacrimal gland lesions in Denmark between 1974 and 2007 Acta Ophthalmol 91 2013 349 354
5. J.E. Wright, G.E. Rose, and A. Garner Primary malignant neoplasms of the lacrimal gland Br J Ophthalmol 76 1992 401 407
6. S.L. von Holstein, S.E. Coupland, and D. Briscoe Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey Acta Ophthalmol 91 2013 195 206
7. T.C. Le, A.R. Razak, and C. Levy Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland Br J Ophthalmol 95 2011 1483 1489
8. A. Nordkvist, J. Mark, and H. Gustafsson Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands Genes Chromosomes Cancer 10 1994 115 121
9. M. Persson, Y. Andren, and J. Mark Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck Proc Natl Acad Sci U S A 106 2009 18740 18744
10. L.B. Brill II, W.A. Kanner, and A. Fehr Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms Mod Pathol 24 2011 1169 1176
11. Y. Mitani, P.H. Rao, and P.A. Futreal Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome Clin Cancer Res 17 2011 7003 7014
12. R.B. West, C. Kong, and N. Clarke MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation Am J Surg Pathol 35 2011 92 99
13. M. Persson, Y. Andren, and C.A. Moskaluk Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma Genes Chromosomes Cancer 51 2012 805 817
14. D. Wetterskog, M.A. Lopez-Garcia, and M.B. Lambros Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers J Pathol 226 2012 84 96
15. C. Marchio, B. Weigelt, and J.S. Reis-Filho Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas) J Clin Pathol 63 2010 220 228
16. M. Hrynchak, V. White, K. Berean, and D. Horsman Cytogenetic findings in seven lacrimal gland neoplasms Cancer Genet Cytogenet 75 1994 133 138
17. A. El-Naggar, and A.G. Huvos Adenoid cystic carcinoma L. Barnes, J.W. Eveson, P. Reichardt, D. Sidransky, Pathology and Genetics of Head and Neck Tumors 2005 IARC Press Lyon, France 221 222 World Health Organization Classification of Tumours.
18. S.E. Edge, D.R. Byrd, C.C. Compton, and A.G. Fritz AJCC Cancer Staging Manual 7th ed. 2009 Springer New York
19. P.A. Szanto, M.A. Luna, M.E. Tortoledo, and R.A. White Histologic grading of adenoid cystic carcinoma of the salivary glands Cancer 54 1984 1062 1069
20. A. Fehr, A. Kovacs, and T. Loning The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma J Pathol 224 2011 322 327
21. K.J. Livak, and T.D. Smittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
22. M.T. Barrett, A. Scheffer, and A. Ben-Dor Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA Proc Natl Acad Sci U S A 101 2004 17765 17770
23. F. Persson, M. Winnes, and Y. Andren High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes Oncogene 27 2008 3072 3080
24. Database of Genomic Variants (NCBI36/hg18) [database online]. Available at: http://dgvbeta.tcag.ca/dgv/app/home. Accessed March 17, 2013.
25. A.J. Iafrate, L. Feuk, and M.N. Rivera Detection of large-scale variation in the human genome Nat Genet 36 2004 949 951
26. Y. Mitani, J. Li, and P.H. Rao Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance Clin Cancer Res 16 2010 4722 4731
27. V.A. Holst, C.E. Marshall, C.A. Moskaluk, and H.F. Frierson Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma Mod Pathol 12 1999 956 960
28. I. Lahortiga, K. De Keersmaecker, and P. Van Vlierberghe Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia Nat Genet 39 2007 593 595
29. A. Abdollahi LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions J Cell Physiol 210 2007 16 25
30. S. Veeriah, B.S. Taylor, and S. Meng Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies Nat Genet 42 2010 77 82
31. M. Hisaoka, A. Tanaka, and H. Hashimoto Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma Lab Invest 82 2002 1427 1435
32. H. Xia, H. Qi, and Y. Li LATS1 tumor suppressor regulates G2/M transition and apoptosis Oncogene 21 2002 1233 1241
33. A.J. Sanders, L. Ye, M.D. Mason, and W.G. Jiang The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis Angiogenesis 13 2010 317 326
34. R.S. Maul, and D.D. Chang EPLIN, Epithelial protein lost in neoplasm Oncogene 18 1999 7838 7841
35. A.M. Ramirez-Herrick, S.E. Mullican, A.M. Sheehan, and O.M. Conneely Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice Blood 117 2011 2681 2690
36. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
37. R.L. Sutherland, and E.A. Musgrove Cyclins and breast cancer J Mammary Gland Biol Neoplasia 9 2004 95 104
38. R. Natrajan, A. Mackay, and P.M. Wilkerson Functional characterization of the 19q12 amplicon in grade III breast cancers [report online] Breast Cancer Res 14 2012 R53 Available at: http://breast-cancer-research.com/content/pdf/ bcr3154.pdf Accessed March 17, 2013.
39. P. Lopez-Bergami, E. Lau, and Z. Ronai Emerging roles of ATF2 and the dynamic AP1 network in cancer Nat Rev Cancer 10 2010 65 76
40. B. Rayet, and C. Gelinas Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 1999 6938 6947
41. D. Kashatus, P. Cogswell, and A.S. Baldwin Expression of the Bcl-3 proto-oncogene suppresses p53 activation Genes Dev 20 2006 225 235
42. S. Adhikary, and M. Eilers Transcriptional regulation and transformation by Myc proteins Nat Rev Mol Cell Biol 6 2005 635 645
43. J.K. Kim, and J.A. Diehl Nuclear cyclin D1: an oncogenic driver in human cancer J Cell Physiol 220 2009 292 296
44. H.F. Frierson Jr., A.K. El-Naggar, and J.B. Welsh Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma Am J Pathol 161 2002 1315 1323
45. R.R. Seethala, K. Cieply, E.L. Barnes, and S. Dacic Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation Arch Pathol Lab Med 135 2011 123 130
46. A. Bernheim, S. Toujani, and P. Saulnier High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma Lab Invest 88 2008 464 473
47. K.L. Ferrazzo, M.M. Neto, and E. dos Santos Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands J Oral Pathol Med 38 2009 701 707
48. H.D. Skinner, A.S. Garden, and D.I. Rosenthal Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experience Cancer 117 2011 2801 2810
49. J. Rootman, and V.A. White Changes in the 7th edition of the AJCC TNM classification and recommendations for pathologic analysis of lacrimal gland tumors Arch Pathol Lab Med 133 2009 1268 1271
50. T. El-Sawy, A. Savar, and M.D. Williams Prognostic accuracy of the seventh edition vs sixth edition of the American Joint Committee on Cancer tumor classification for adenoid cystic carcinoma of the lacrimal gland Arch Ophthalmol 130 2012 664 666